BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shagufta, Ahmad I. The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2. Eur J Med Chem 2021;213:113157. [PMID: 33486200 DOI: 10.1016/j.ejmech.2021.113157] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Pérez-Vargas J, Shapira T, Olmstead AD, Villanueva I, Thompson CAH, Ennis S, Gao G, De Guzman J, Williams DE, Wang M, Chin A, Bautista-Sánchez D, Agafitei O, Levett P, Xie X, Nuzzo G, Freire VF, Quintana-Bulla JI, Bernardi DI, Gubiani JR, Suthiphasilp V, Raksat A, Meesakul P, Polbuppha I, Cheenpracha S, Jaidee W, Kanokmedhakul K, Yenjai C, Chaiyosang B, Teles HL, Manzo E, Fontana A, Leduc R, Boudreault PL, Berlinck RGS, Laphookhieo S, Kanokmedhakul S, Tietjen I, Cherkasov A, Krajden M, Nabi IR, Niikura M, Shi PY, Andersen RJ, Jean F. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics. Antiviral Res 2023;209:105484. [PMID: 36503013 DOI: 10.1016/j.antiviral.2022.105484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Khattab ESAEH, Ragab A, Abol-Ftouh MA, Elhenawy AA. Therapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral spike proteins. J Biomol Struct Dyn 2022;40:13291-309. [PMID: 34647855 DOI: 10.1080/07391102.2021.1989036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
3 Sulimov A, Ilin I, Kutov D, Shikhaliev K, Shcherbakov D, Pyankov O, Stolpovskaya N, Medvedeva S, Sulimov V. New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture. Molecules 2022;27:5732. [PMID: 36080498 DOI: 10.3390/molecules27175732] [Reference Citation Analysis]
4 Hu Q, Xiong Y, Zhu GH, Zhang YN, Zhang YW, Huang P, Ge GB. The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19. MedComm (2020) 2022;3:e151. [PMID: 35845352 DOI: 10.1002/mco2.151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Alzyoud L, Ghattas MA, Atatreh N. Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents. DDDT 2022;Volume 16:2463-2478. [DOI: 10.2147/dddt.s370574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Bogdanov AV, Voloshina AD, Lyubina AP, Amerkhanova SK, Glukhareva TV, Mironov VF. Sterically Hindered Phenolic Isatin Derivatives Containing a DABCO Fragment: Synthesis and Antimicrobial Activity Testing. Russ J Org Chem 2022;58:1067-1075. [DOI: 10.1134/s1070428022080012] [Reference Citation Analysis]
7 Sureja DK, Shah AP, Gajjar ND, Jadeja SB, Bodiwala KB, Dhameliya TM. In‐silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV‐2. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202202069] [Reference Citation Analysis]
8 Bogdanov AV, Sirazieva AR, Voloshina AD, Abzalilov TA, Samorodov AV, Mironov VF. Synthesis and Antimicrobial, Antiplatelet, and Anticoagulant Activities of New Isatin Deivatives Containing a Hetero-Fused Imidazole Fragment. Russ J Org Chem 2022;58:327-34. [DOI: 10.1134/s1070428022030101] [Reference Citation Analysis]
9 Dhameliya TM, Nagar PR, Gajjar ND. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations. Mol Divers 2022. [PMID: 35132518 DOI: 10.1007/s11030-022-10394-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Chenna A, Khan WH, Dash R, Rathore AS, Goel G. Template-based design of peptides to inhibit SARS-CoV-2 RNA-dependent RNA polymerase complexation.. [DOI: 10.1101/2022.01.24.477502] [Reference Citation Analysis]
11 Zhang JW, Xiong Y, Wang F, Zhang FM, Yang X, Lin GQ, Tian P, Ge G, Gao D. Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19. Eur J Med Chem 2022;228:114030. [PMID: 34883292 DOI: 10.1016/j.ejmech.2021.114030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Oyagbemi AA, Ajibade TO, Aboua YG, Gbadamosi IT, Adedapo ADA, Aro AO, Adejumobi OA, Thamahane-Katengua E, Omobowale TO, Falayi OO, Oyagbemi TO, Ogunpolu BS, Hassan FO, Ogunmiluyi IO, Ola-Davies OE, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Kayoka-Kabongo PN, Yakubu MA, Oguntibeju OO. The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19. Vet World 2021;14:2705-13. [PMID: 34903929 DOI: 10.14202/vetworld.2021.2705-2713] [Reference Citation Analysis]
13 Nagar PR, Gajjar ND, Dhameliya TM. In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis. J Mol Struct 2021;1246:131190. [PMID: 34334813 DOI: 10.1016/j.molstruc.2021.131190] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
14 Srour AM, Panda SS, Mostafa A, Fayad W, El-Manawaty MA, A F Soliman A, Moatasim Y, El Taweel A, Abdelhameed MF, Bekheit MS, Ali MA, Girgis AS. Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties. Bioorg Chem 2021;117:105466. [PMID: 34775204 DOI: 10.1016/j.bioorg.2021.105466] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
15 Shagufta, Ahmad I. An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS-CoV-2 Activity. ChemistrySelect 2021;6:11502-27. [PMID: 34909460 DOI: 10.1002/slct.202103301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Pozzi G, Masselli E, Gobbi G, Mirandola P, Taborda-Barata L, Ampollini L, Carbognani P, Micheloni C, Corazza F, Galli D, Carubbi C, Vitale M. Hydrogen Sulfide Inhibits TMPRSS2 in Human Airway Epithelial Cells: Implications for SARS-CoV-2 Infection. Biomedicines 2021;9:1273. [PMID: 34572459 DOI: 10.3390/biomedicines9091273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
17 Chen GY, Pan YC, Wu TY, Yao TY, Wang WJ, Shen WJ, Ahmed A, Chan ST, Tang CH, Huang WC, Hung MC, Yang JC, Wu YC. Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay. J Tradit Complement Med 2021. [PMID: 34549024 DOI: 10.1016/j.jtcme.2021.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Seliem IA, Girgis AS, Moatasim Y, Kandeil A, Mostafa A, Ali MA, Bekheit MS, Panda SS. New Pyrazine Conjugates: Synthesis, Computational Studies, and Antiviral Properties against SARS-CoV-2. ChemMedChem 2021. [PMID: 34352160 DOI: 10.1002/cmdc.202100476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Chitsike L, Duerksen-Hughes P. Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics. Virol J 2021;18:154. [PMID: 34301275 DOI: 10.1186/s12985-021-01624-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
20 Sivakumar D, Stein M. Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases. Biomolecules 2021;11:802. [PMID: 34071582 DOI: 10.3390/biom11060802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Shapira T, Monreal IA, Dion SP, Jager M, Désilets A, Olmstead AD, Vandal T, Buchholz DW, Imbiakha B, Gao G, Chin A, Rees WD, Steiner T, Nabi IR, Marsault E, Sahler J, August A, Van de Walle G, Whittaker GR, Boudreault PL, Aguilar HC, Leduc R, Jean F. A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice. bioRxiv 2021:2021. [PMID: 33972944 DOI: 10.1101/2021.05.03.442520] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
22 Rossi FV, Gentili D, Marcantoni E. Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis. Molecules 2021;26:2620. [PMID: 33947170 DOI: 10.3390/molecules26092620] [Reference Citation Analysis]